SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 10.57% in the revenue at Rs. 14145.20 millions was reported in the March 2024 quarter as compared to Rs. 12793.40 millions during year-ago period.Profit saw a slight increase of 18.62%to Rs. 1213.20  millions from Rs. 1022.80 millions.Operating profit for the quarter ended March 2024 rose to 2952.00 millions as compared to 2583.80 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 14145.20 12793.40 10.57 48123.90 57734.50 -16.65 48123.90 57734.50 -16.65
Other Income 240.90 59.40 305.56 474.20 159.50 197.30 474.20 159.50 197.30
PBIDT 2952.00 2583.80 14.25 7973.00 14977.10 -46.77 7973.00 14977.10 -46.77
Interest 419.90 410.30 2.34 1508.20 1457.00 3.51 1508.20 1457.00 3.51
PBDT 2532.10 2173.50 16.50 6464.80 13520.10 -52.18 6464.80 13520.10 -52.18
Depreciation 889.00 805.50 10.37 3450.10 3005.80 14.78 3450.10 3005.80 14.78
PBT 1643.10 1368.00 20.11 3014.70 10514.30 -71.33 3014.70 10514.30 -71.33
TAX 429.90 345.20 24.54 777.70 2910.50 -73.28 777.70 2910.50 -73.28
Deferred Tax -29.50 270.80 -110.89 -101.70 202.70 -150.17 -101.70 202.70 -150.17
PAT 1213.20 1022.80 18.62 2237.00 7603.80 -70.58 2237.00 7603.80 -70.58
Equity 1077.90 1077.30 0.06 1077.90 1077.30 0.06 1077.90 1077.30 0.06
PBIDTM(%) 20.87 20.20 3.33 16.57 25.94 -36.13 16.57 25.94 -36.13

Laurus Labs Share Price

1114.80 0.30 (0.03%)
22-Apr-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.60
Dr. Reddys Lab 1214.95
Cipla 1228.85
Zydus Lifesciences 927.30
Lupin 2306.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×